These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 26723893)

  • 1. Kinase profiling in early stage drug discovery: sorting things out.
    Defert O; Boland S
    Drug Discov Today Technol; 2015 Nov; 18():52-61. PubMed ID: 26723893
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Protein kinase profiling assays: a technology review.
    Wang Y; Ma H
    Drug Discov Today Technol; 2015 Nov; 18():1-8. PubMed ID: 26723886
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Extending kinome coverage by analysis of kinase inhibitor broad profiling data.
    Jacoby E; Tresadern G; Bembenek S; Wroblowski B; Buyck C; Neefs JM; Rassokhin D; Poncelet A; Hunt J; van Vlijmen H
    Drug Discov Today; 2015 Jun; 20(6):652-8. PubMed ID: 25596550
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bacterial histidine kinases as novel antibacterial drug targets.
    Bem AE; Velikova N; Pellicer MT; Baarlen Pv; Marina A; Wells JM
    ACS Chem Biol; 2015 Jan; 10(1):213-24. PubMed ID: 25436989
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pocketome of human kinases: prioritizing the ATP binding sites of (yet) untapped protein kinases for drug discovery.
    Volkamer A; Eid S; Turk S; Jaeger S; Rippmann F; Fulle S
    J Chem Inf Model; 2015 Mar; 55(3):538-49. PubMed ID: 25557645
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A broad activity screen in support of a chemogenomic map for kinase signalling research and drug discovery.
    Gao Y; Davies SP; Augustin M; Woodward A; Patel UA; Kovelman R; Harvey KJ
    Biochem J; 2013 Apr; 451(2):313-28. PubMed ID: 23398362
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Unexpected off-targets and paradoxical pathway activation by kinase inhibitors.
    Hantschel O
    ACS Chem Biol; 2015 Jan; 10(1):234-45. PubMed ID: 25531586
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Discovery of a new class of highly potent necroptosis inhibitors targeting the mixed lineage kinase domain-like protein.
    Yan B; Liu L; Huang S; Ren Y; Wang H; Yao Z; Li L; Chen S; Wang X; Zhang Z
    Chem Commun (Camb); 2017 Mar; 53(26):3637-3640. PubMed ID: 28267172
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The design, annotation, and application of a kinase-targeted library.
    Xi H; Lunney EA
    Methods Mol Biol; 2011; 685():279-91. PubMed ID: 20981529
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Quantitative proteomics of kinase inhibitor targets and mechanisms.
    Daub H
    ACS Chem Biol; 2015 Jan; 10(1):201-12. PubMed ID: 25474541
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The evolution of protein kinase inhibitors from antagonists to agonists of cellular signaling.
    Dar AC; Shokat KM
    Annu Rev Biochem; 2011; 80():769-95. PubMed ID: 21548788
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bioinformatics in protein kinases regulatory network and drug discovery.
    Chen Q; Luo H; Zhang C; Chen YP
    Math Biosci; 2015 Apr; 262():147-56. PubMed ID: 25656386
    [TBL] [Abstract][Full Text] [Related]  

  • 13. System-based drug discovery within the human kinome.
    Bamborough P
    Expert Opin Drug Discov; 2012 Nov; 7(11):1053-70. PubMed ID: 22971083
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 25 years of small molecular weight kinase inhibitors: potentials and limitations.
    Fabbro D
    Mol Pharmacol; 2015 May; 87(5):766-75. PubMed ID: 25549667
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Kinase Atlas: Druggability Analysis of Potential Allosteric Sites in Kinases.
    Yueh C; Rettenmaier J; Xia B; Hall DR; Alekseenko A; Porter KA; Barkovich K; Keseru G; Whitty A; Wells JA; Vajda S; Kozakov D
    J Med Chem; 2019 Jul; 62(14):6512-6524. PubMed ID: 31274316
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sequence-based protein kinase inhibition: applications for drug development.
    Wexler I; Niv M; Reuveni H
    Biotechniques; 2005 Oct; 39(10 Suppl):S575-6. PubMed ID: 18957040
    [No Abstract]   [Full Text] [Related]  

  • 17. Methods in Enzymology. Protein kinase inhibitors in research and medicine. Preface.
    Shokat KM
    Methods Enzymol; 2014; 548():xi-xii. PubMed ID: 25399648
    [No Abstract]   [Full Text] [Related]  

  • 18. Natural products as a source of protein kinase activators and inhibitors.
    Marston A
    Curr Top Med Chem; 2011; 11(11):1333-9. PubMed ID: 21513498
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Structure-based discovery of inhibitors of the YycG histidine kinase: new chemical leads to combat Staphylococcus epidermidis infections.
    Qin Z; Zhang J; Xu B; Chen L; Wu Y; Yang X; Shen X; Molin S; Danchin A; Jiang H; Qu D
    BMC Microbiol; 2006 Nov; 6():96. PubMed ID: 17094812
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Editorial: Recent Advances in the Field of Kinases and Kinase Inhibitors.
    Huang Z; Lee MH
    Curr Pharm Des; 2017 Nov; 23(29):4207-4208. PubMed ID: 29231803
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.